{"id":95609,"date":"2026-03-25T17:47:30","date_gmt":"2026-03-25T16:47:30","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=customer-stories&p=95609"},"modified":"2026-05-06T13:47:40","modified_gmt":"2026-05-06T11:47:40","slug":"sanofi-clinical-study-training","status":"publish","type":"customer-stories","link":"https:\/\/www.veeva.com\/eu\/customer-stories\/sanofi-clinical-study-training\/","title":{"rendered":"Sanofi"},"content":{"rendered":"

\nStudy training is a significant yet often hidden cost in clinical trials. For an average Phase 2 study with 40 sites, study training costs can exceed $200,000<\/a> \u2013 assuming that everyone completes training once and correctly. With retraining, that figure can jump to $350,000.\n<\/p>\n

\nDelphine Maillard, head of clinical learning and development at Sanofi, knew these challenges well. As a top 10 biopharma with over 80,000 employees, Sanofi lacked an internal system to train site staff. Instead, Maillard\u2019s team relied on multiple, disparate systems provided by service providers.\n<\/p>\n

\n\u201cWhen you don\u2019t have a centralized system, it\u2019s not possible to reconcile all the training information. Ultimately, that is what brought us to ³Ô¹Ï±¬ÁÏ Study Training,\u201d explains Maillard. Since consolidating three previous systems into a single platform, the company is on track to reduce study training costs by an estimated 30%.\n<\/p>\n

Saving time with automated study training workflows<\/h2>\n

\nMaillard points to several ³Ô¹Ï±¬ÁÏ Study Training capabilities that help Sanofi save time and improve oversight:<\/p>\n